Gamida Cell Ltd
NASDAQ:GMDA
Gamida Cell Ltd
NASDAQ:GMDA
Price:
0.0184 USD
2.22%
Market Closed
Updated:
May 3, 2024
Gamida Cell Ltd
Cash from Financing Activities
|
Gamida Cell Ltd
Cash from Financing Activities Peer Comparison
Comparables:
CLGN
KMDA
URGN
ENTX
B
BONS
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Gamida Cell Ltd
NASDAQ:GMDA
|
Cash from Financing Activities
$61.8m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
|
Collplant Biotechnologies Ltd
NASDAQ:CLGN
|
Cash from Financing Activities
$1.1m
|
CAGR 3-Years
-37%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
N/A
|
|
|
Kamada Ltd
NASDAQ:KMDA
|
Cash from Financing Activities
$22.7m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-7%
|
|
|
Urogen Pharma Ltd
NASDAQ:URGN
|
Cash from Financing Activities
$116.9m
|
CAGR 3-Years
92%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
|
|
Entera Bio Ltd
NASDAQ:ENTX
|
Cash from Financing Activities
$6m
|
CAGR 3-Years
14%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
|
B
|
Bonus Biogroup Ltd
TASE:BONS
|
Cash from Financing Activities
-₪1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Gamida Cell Ltd's Cash from Financing Activities?
Cash from Financing Activities
61.8m
USD
61.8m
USD
Based on the financial report for Dec 31, 2023, Gamida Cell Ltd's Cash from Financing Activities amounts to 61.8m USD.
What is Gamida Cell Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
5%
5%
Over the last year, the Cash from Financing Activities growth was 37%. The average annual Cash from Financing Activities growth rates for Gamida Cell Ltd have been -23% over the past three years , 5% over the past five years .
You don't have any saved screeners yet
